Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trial
Marcel Émond, Patrick Archambault, Alexis Cournoyer, Debra Eagles et al.
Citations
2 citations
Journal
BMJ
Topics
Atrial Fibrillation Management and Outcomes
Field-Weighted Citation Impact (FWCI)
2.78
article
Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trial
Marcel Émond, Patrick Archambault, Alexis Cournoyer, Debra Eagles, Marco L.A. Sivilotti, Jeffrey J. Perry, Éric Mercier, David H. Birnie, Erica Brown, Judy Morris, Ratika Parkash, Laurent Macle, Krishan Yadav, Corinne M. Hohl, Samuel Campbell, Andrew D. McRae, Ian G. Stiell, Monica Taljaard, Kednapa Thavorn, Alain Vadeboncœur, Yutong Chen, David Paré, Stuart G. Nicholls, Kerstin de Wit, Marie‐Joe Nemnom, Catherine M. Clement, Ghadeer Mohamad
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJVol. 391
Institutions
Dalhousie University (CA), Vancouver Coastal Health (CA), University of British Columbia (CA), University of Ottawa (CA), University of Calgary (CA), Queen's University (CA), Montreal Heart Institute (CA), Ottawa Hospital (CA), South Health Campus (CA), Centre Intégré de Santé et Services Sociaux de Chaudière-Appalache (CA), Hôpital de l'Enfant-Jésus (CA), Institut universitaire de cardiologie et de pneumologie de Québec (CA), Centre hospitalier de l'Université Laval (CA), Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal (CA), Vancouver Coastal Health Research Institute (CA), Université Laval (CA), Ottawa Hospital Research Institute (CA), Université de Montréal (CA)